Neuroleptic malignant syndrome following withdrawal of amantadine in a patient with influenza A encephalopathy

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Pediatrics

• Publication date

  2001-05-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s004310100743PMID 11421428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroleptic malignant syndrome and amantadine withdrawal.

  1985cited by this paper
• Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine.

  1984cited by this paper
• Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs.

  1981cited by this paper
• Neuroleptic malignant syndrome

  1981cited by this paper
• Neuroleptic malignant syndrome.

  1980cited by this paper

• Síndrome neuroléptico maligno en ni ˜nos y adolescentes: revisión sistemática de reportes de caso

  2021cites this paper
• Amantadine and memantine: a comprehensive review for acquired brain injury

  2020cites this paper
• Neuroleptic Malignant Syndrome in Children and Adolescents: Systematic Review of Case Reports.

  2020cites this paper
• Neuroleptic malignant syndrome in children and adolescents: Systematic review of case reports.

  2019cites this paper
• Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development

  2019cites this paper
• Neurostimulant use is associated with improved survival in comatose patients after cardiac arrest regardless of electroencephalographic substrate.

  2018cites this paper
• Excited Delirium and Sudden Death: A Syndromal Disorder at the Extreme End of the Neuropsychiatric Continuum

  2016cites this paper
• Disorders of body temperature.

  2014cites this paper
• Case Reports of Neuroleptic Malignant Syndrome in Context of Quetiapine Use

  2013cites this paper
• JUSTIFICATIVA E OBJETIVOS: A síndrome neuroléptica

  2012cites this paper
• Drug-induced movement disorders: emergencies and management.

  2012cites this paper
• The tardive syndromes

  2011cites this paper
• Neuroleptic Malignant Syndrome

  2011cites this paper
• Case files of the Program in Medical Toxicology at Brown University: Amantadine withdrawal and the neuroleptic malignant syndrome

  2009cites this paper
• Pharmacotherapy to enhance arousal: what is known and what is not.

  2009cites this paper
• Status epilepticus in a pediatric patient with amantadine overdose.

  2009cites this paper
• Contemporary controversies in the definition of death.

  2009cites this paper
• Neuroleptic malignant syndrome.

  2008cites this paper
• Fatal Neurotoxic Response to Neuroleptic Medications: Case Report and Review of the Literature

  2007cites this paper
• Pharmacokinetic Characterization of Amantadine in Human Brain Tissue

  2006cites this paper
• Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment

  2004cites this paper
• The Use of Amantadine in Parkinson's Disease and other Akinetic-Rigid Disorders

  2004cites this paper
• Current Awareness

  2001cites this paper
• Pharmacoepidemiology and drug safety

  2001cites this paper